V632 QAPI area: anemia management
Written V0632 on the CMS-2567 and in QCOR.
Cited on this tag? What happens after a citation · One-page sheet for the binder
The regulation
§ 494.110 (a)(2) – The program must include, but not be limited to, the following: (iv) Anemia management.
CMS's interpretive guidance
Interpretive Guidance § 494.110(a)(2)(iv):
The intent of QAPI in addressing anemia management is to maximize the number of patients who achieve the goals in this area. Refer to the Measures Assessment Tool (MAT) which lists the current professionally-accepted clinical practice standards and CMS CPMs in this and other areas.
For anemia management, factors that should be tracked monthly for the facility's patient population as a whole include laboratory values for hemoglobin and hematocrit. If facility QAPI goals for anemia management are not achieved over consecutive evaluation periods, the facility IDT should conduct a review of: transferrin saturation (TSAT) levels, ferritin levels, and other iron indices; erythropoietin stimulating agent (ESA) doses and response to those doses; and, any evidence of blood loss, such as repeated episodes of insufficient rinseback of red blood cells or prolonged bleeding post treatment.
If the facility uses a standardized anemia management guideline or algorithm, the IDT should evaluate the efficacy of this tool if facility QAPI goals for anemia management are not achieved over consecutive evaluation periods.
Home and in-center patient outcomes may need to be reviewed separately by the facility in this area as the factors to be addressed may be different. For example, a home peritoneal patient may be reluctant to inject himself/herself with an ESA, resulting in lower values for this measure in the home population.
https://middlemolecule.com/rulebook/tags/v632/